FBInvestor
Stocks / Crinetics Pharmaceuticals In
Institutional Ownership

Crinetics Pharmaceuticals In

CUSIP 22663K107COMCRNXQ1 2026

Earnings

Quarterly EPS and revenue are sourced from SEC XBRL financial statements. We ingest the top issuers first; this fills in as coverage expands (or this security isn't mapped to an SEC filer yet).

Coming soon